Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.68 (
tissue plasminogen activator
)
11,311
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pofut1
gene encodes a O-fucosyltransferase that adds fucose to the serine/threonine residue in the sequence of C
2
XXXX(S/T)C
3
of EGF-like domain in a protein. O-fucosylation has been shown to be required for some EGF-like domain-containing proteins to function, e.g., Notch1, and
POFUT1
deficiency could affect cellular function and cause diseases.
Pofut1
is ubiquitously expressed, but its essentiality for most cell types is not known. In the present study, we examined the consequence of Pofut1 gene abrogation in mouse podocytes using Cre-loxP system, and found that the conditional knockout mice were indistinguishable from wild-type controls in urinary protein level, glomerular morphology, podocyte foot process ultrastructure, podocyte marker expression and podocyte numbers. These results indicated that
POFUT1
is not essential for podocyte structure, function and survival in mice. To understand why
POFUT1
is dispensable for podocytes, we searched mouse podocyte essential gene candidates (as determined by single-cell RNA-seq) and found only two
POFUT1
substrates, NOTCH2 and
tPA
. It has been shown that abrogation of these genes does not cause podocyte injury, explaining dispensability of
POFUT1
for mouse podocytes and demonstrating a feasibility to predict
POFUT1
essentiality for a given cell type. At present, most mouse cell types have been subject to single-cell RNA-seq, making essential gene prediction and thus
POFUT1
requirement prediction possible for the cell types.
...
PMID:POFUT1 is dispensable for structure, function and survival of mouse podocytes. 3250 13